Bosutinib Recruiting Phase 2 Trials for Chronic / BCR-ABL Positive / Myelogenous / Leukemias Treatment

IndicationsStatusPurposePhase
RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02638467Allogeneic Stem Cell Transplantation in Chronic Myeloid Leukemia Failing TKIs Therapy